Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,613.71
(
0.87%
)
US TECH 100
23,625.00
(
1.14%
)
Dow Jones
46,533.92
(
0.89%
)
Brent Oil
96.76
(
0.26%
)
Bitcoin
71,233.68
(
1.02%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jessellivermore post# 9428

Sunday, 04/06/2008 4:00:59 PM

Sunday, April 06, 2008 4:00:59 PM

Post# of 19309
Re: DIC

>The reason heparin might prevent the benefits of AT3 in DIC is that heparin is bound to the same site on AT3 that would interact with the surface receptor on the immune cell.<

Has the second part of this sentence—the part about the binding site—been conclusively established? T.i.a.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today